- Kamiko K, Aoki K, Kamiyama H, Taguri M, Shibata E, Ashiya Y, Minagawa F, Shinoda K, Nakajima S, Terauchi Y. Comparison of the administration of teneligliptin every day versus every other day in Japanese patients with type 2 diabetes: A randomized non-inferior test.J Clin Pharmacol. 55(2): 144-151, 2015.
- Nakamura A, Terauchi Y. Present status of clinical deployment of glucokinase activators. [Review]J Diabetes Invest, 6: 124-132, 2015.
- Inoue Y, Nakamura A, Kondo Y, Hamano K, Satoh S, Terauchi Y. A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes.J Clin Pharmacol, 55(7): 831-8, 2015.
- Nozaki Y, Fujita K, Wada K, Yoneda M, Kessoku T, Shinohara Y, Imajo K, Ogawa Y, Nakamuta M, Saito S, Masaki N, Nagashima Y, Terauchi Y, Nakajima A. Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.BMC Gastroenterology, 15(1): 42, 2015.
- Maeda H, Kubota A, Kanamori A, Tanaka Y, Terauchi Y, Matsuba I, The Study Group of the Diabetes Committee, Kanagawa Physicians Association. Effects of sitagliptin on the serum creatinine in Japanese type 2 diabetes.Diabetes Res. Clin. Pract., 108(3):e42-5, 2015.
- Ishikawa M, Takai M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T, Uehara G, Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T, Takeda H, Tanaka K, Tsurui N, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, Minagawa F, Minami N, Miyairi Y, Mokubo A, Motomiya T, Waseda M, Miyakawa M, Naka Y, Terauchi Y, Tanaka Y, Matsuba I. Factors predicting therapeutic efficacy of combination treatment with sitagliptin and insulin in type 2 diabetic patients: The ASSIST-K Study.J Clin Med Res, 7(8):607-12, 2015.
- Takihata M, Nakamura A, Kondo Y, Kawasaki S, Kimura M, Terauchi Y. Comparison of azelnidipine and trichlormethiazide in Japanese type 2 diabetic patients with hypertension: the COAT randomized controlled trial.PloS ONE, 2015 May 4;10(5):e0125519.
- Inoue K, Goto A, Kishimoto M, Tsujimoto T, Yamamoto-Honda R, Noto H, Kajio H, Terauchi Y, Noda M. Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases.Clin Exp Nephrol. 2015 Apr 1. [Epub ahead of print]
- Kadowaki T, Haneda M, Inagaki N, Terauchi Y, Taniguchi A, Koiwai K, Rattunde H, Woerle HJ, Broedl UC. Efficacy and safety of empagliflozin monotherapy for 52 weeks in Japanese patients with type 2 diabetes: A randomized, double-blind, parallel-group study.Adv Ther. 32(4):306-18, 2015.
- Aoki K, Iijima T, Kamiyama H, Kamiko K, Terauchi Y. Anagliptin decreases serum lathosterol level in patients with type 2 diabetes: A pilot study.Expert Opin Pharmacother, 2015 Jun 22:1-6. [Epub ahead of print]
- Kaku K, Kadowaki T, Terauchi Y, Okamoto T, Sato A, Okuyama K, Juan Camilo Arjona Ferreira, Goldstein BJ. Sitagliptin improves glycemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance.Diabetes Obes Metab, 2015 Jun 12. doi: 10.1111/dom.12507. [Epub ahead of print]
- Umezawa S, Kubota A, Maeda H, Kanamori A, Matoba K, Jin Y, Minagawa F, Obana M, Iemitsu K, Ito S, Amamiya H, Kaneshiro M, Takai M, Kaneshige H, Hoshino K, Ishikawa M, Minami N, Takuma T, Sasai N, Aoyagi S, Kawata T, Mokubo A, Miyairi Y, Takeda H, Honda S, Machimura H, Motomiya T, Waseda M, Naka Y, Tanaka Y, Terauchi Y, Matsuba I. Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study.BMC Endocrine Disorders, 2015 Jul 3;15:34.
- Kondo Y, Satoh S, Nezu Osada U, Terauchi Y. Early liraglutide treatment improves β-cell function in patients with type 2 diabetes: A retrospective cohort study.Endocr J, in press, 2015.
- Yoshii T, Yamada M, Minami T, Tsunoda T, Sasaki M, Kondo Y, Satoh S, Terauchi Y. The effects of bazedoxifene on bone, glucose, and lipid metabolism in postmenopausal women with type 2 diabetes: An exploratory pilot study.J Clin Med Res, in press, 2015.
- Ono K, Nakamura A, Kawaguchi J, Takihata M, Inoue Y, Shirakawa J, Kameda A, Togashi Y, Hayashi T, Furuki T, Ito S, Takano T, Kawasaki S, Takeda H, Kaneko T, Kimura M, Mizushima S, Terauchi Y. The Safety, Efficacy and Treatment Satisfaction Comparison of Unchanged Premixed Insulin Regimen Plus Sitagliptin with Switch from the Premixed Insulin to Once-Daily Basal Insulin Plus Sitagliptin in Patients with Inadequately Controlled Type 2 Diabetes with Twice-Daily Premixed Insulin.Int J Diabetes Clin Res 2:4, 2015.
- Terauchi Y, Naito Y, Ikeda Y. Evaluation of unmet medical need among Japanese patients with type 2 diabetes mellitus and efficacy of Lixisenatide treatment among Asian type 2 diabetes mellitus patients.Diabetes Metab Syndr. 2015 Aug 22. pii: S1871-4021(15)00075-2.
- Emoto M, Terauchi Y, Ozeki A, Oura T, Takeuchi M, Imaoka T. A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial.Endocr. J., in press, 2015.
- Iizuka T, Iemitsu K, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Kawata T, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H, Minagawa F, Saito T, Shinoda K, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I. Efficacy and Safety of Ipragliflozin in Japanese Patients with Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study.J Clin Med Res, in press, 2015.
- Nakamura A, Mitsuhashi T, Takano Y, Miyoshi H, Kameda H, Nomoto H, Nagai S, Hatanaka Y, Shimizu C, Terauchi Y, Atsumi T. Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas.Endocr J. 2015 Nov 14. [Epub ahead of print]
- Komatsu Y, Nakamura A, Takihata M, Inoue Y, Yahagi S, Tajima K, Tsuchiya H, Takano T, Yamakawa T, Yoshida M, Miyoshi H, Terauchi Y. Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia.Endocr J. 2015 Nov 20. [Epub ahead of print]
- Ito Y, Shibuya M, Hosokawa S, Motoki Y, Nagata R, Konishi H, Miyazaki T, Matsunaga T, Nomura Y, Mihara T, Ito S, Sugiura K, Terauchi Y. Indicators of the need for insulin treatment and the effect of treatment for gestational diabetes on pregnancy outcomes in Japan.Endocr J. 2015 Nov 25. [Epub ahead of print]
- Terauchi Y, Koyama M, Cheng X, Takahashi Y, Riddle MC, Bolli GB, Hirose T. New insulin glargine 300 U/mL versus glargine 100 U/mL in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drug(s): glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).Diabetes Obes Metab, 2015 Dec 11. doi: 10.1111/dom.12618. [Epub ahead of print]
- Okamoto Y, Yamakawa T, Terauchi Y. Aging may affect insulin action independent of adiposity in non-diabetic subjects. [Review]J Atheroscler Thromb. 2015 Dec 19. [Epub ahead of print]
- Nozaki Y, Fujita K, Wada K, Yoneda M, Shinohara Y, Imajo K, Ogawa Y, Kessoku T, Nakamuta M, Saito S, Masaki N, Nagashima Y, Terauchi Y, Nakajima A. Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution BMC Gastroenterol. 2015 Dec 17;15(1):177.
